cancerfacts.com - log on. fight back.  
General Services
Cancer News
  Personal Stories
  Support Groups
  Links and Resources
Help Center
  Help
  Contact Us
  Suggestion Box
About Us
  About cancerfacts.com
  cancerfacts.com
    in the News
  Visitor Comments







Sperm banking aids fatherhood after testicular cancer
Source: (Reuters Health)
Wednesday, January 03, 2001



NEW YORK, Jan 03 - Testicular cancer is a disease that commonly strikes young men, making the effects of treatment on fertility an important concern. Now from Norway come results of a study looking at how well some of these patients recover their ability to produce sperm and what options are open to them.

Dr. Sophie D. Fossa, of The Norwegian Radium Hospital in Oslo, and colleagues studied 60 cancer patients who underwent a surgical procedure called orchiectomy, where the cancerous testicle is removed. Most of the men had regained their normal sperm counts after surgery and almost half became fathers, representing 78 percent of those who were trying to have a child, according to the report in the January issue of The Journal of Urology.

But Fossa noted, it is not unusual for some patients to experience decreased sperm production in the remaining testicle following surgery. "Ten or 15 years ago (many) urologists thought this type of reduced (sperm production) always was permanent. Therefore, aggressive further chemotherapy would be more justified based on the assumption that these men would, in any case, not be able to father a child," the researcher told Reuters Health.

As a consequence, she continued, the type of surgical procedure often performed in the past "destroyed the ejaculatory functions."

But Fossa and her colleagues found that even some patients with initially low sperm counts will experience a "transient" period of normal sperm levels for perhaps a year after surgery.

"Today's surgeons and oncologists have to consider this spontaneous recovery when planning and timing (the) treatment after orchiectomy in a patient who most probably does not have any metastases," Fossa explained. Metastases are secondary cancers that occur when cancer spreads to other sites in the body.

These metastases-free patients may be good candidates for what is termed a "surveillance policy." That is, no further treatment after the orchiectomy.

Fossa also pointed out that patients who have low sperm counts going into orchiectomy were often not given the option to bank their sperm "because of the low success rate of assisted fertilization. This has changed with better methods of in vitro fertilization."

Fossa suggested that patients who are on surveillance should be offered "multiple sperm banking" in the year after their orchiectomy, to take advantage of the temporary rise in sperm production "even in cases who may seem to be 'hopeless' at their first sperm analysis."

Moreover, she added, patients should ask for "at least one sperm analysis at the time of diagnosis, which should be repeated if no further treatment is given and the initial sperm count was low."

In her view, it is important for patients to know that "correct timing and sperm banking may give a true chance of post-orchiectomy fatherhood."

SOURCE: The Journal of Urology 2001;165:93-96.

Copyright © 2000 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.








Top


Powered By Nexcura

   Terms and Conditions
   Privacy Statement
   Trademark and Copyright


  search by keyword




GO

Advanced Search


Son's testicular cancer worse than dad's

Men who develop testicular cancer have fertility problems






Bladder
Breast
Cervical
Colorectal
Hodgkin's Disease
Kidney
Leukemia - Adult ALL
Leukemia - Adult AML
Leukemia - Adult CML
Lung - Non-Small Cell
Lung - Small Cell
Melanoma
Multiple Myeloma
Non-Hodgkin's Lymphoma
Oral Cavity and Oropharynx
Ovarian
Pancreatic
Prostate
Testicular
Uterine




HON Logo
We subscribe to the
HONcode principles
of the
Health On the Net
Foundation






HOME | CONTACT US | SUGGESTION BOX


cancerfacts.com, the cancerfacts.com logo, NexProfiler, NexCura, Heart Profiler, the NexProfiler logo, the NexCura logo, the Heart Profiler logo and the Powered by NexCura logo are either trademarks or registered trademarks of NexCura, Inc. Copyright © 2005 NexCura, Inc. All rights reserved. U.S. Patent No. 6,581,038 & Patents Pending. Other foreign patents may apply. This information is for educational purposes only.